# Neonatal Meningitis

Neonatal meningitis requires prompt cerebrospinal fluid evaluation and hospital-based empiric antimicrobial therapy because clinical findings are nonspecific, culture sensitivity falls after antibiotics, and delayed recognition risks death and neurodevelopmental disability.

**Clinical question:** How should clinicians evaluate and treat suspected bacterial meningitis in neonates and young infants?

Updated: 2026-08-21T01:21:18.302025+00:00

## What matters in practice
- Clinical findings are often nonspecific in neonates; early recognition and empiric treatment are central management priorities. [15][22]
- CSF culture remains the diagnostic reference standard, but its sensitivity is reduced by antecedent antibiotic exposure. [4][11]
- When clinically feasible, obtain CSF before antimicrobial therapy; lumbar puncture may compromise respiratory status in unstable neonates. [3][7]
- For young infants with suspected meningitis, IV aminopenicillins and third- or fourth-generation cephalosporins are supported by CSF penetration data; cefotaxime has traditionally been favored over ceftriaxone because of bilirubin-displacement concerns. [19]
- Available guidance summarized in a recent systematic review supports hospital treatment for up to 3 weeks when the pathogen is unknown, although the underlying evidence is largely historical and expert-opinion based. [19]

## Maintain a low threshold for meningitis evaluation

Neonatal presentation is frequently subtle and overlaps with sepsis.

Neonatal meningitis remains difficult to recognize early because affected infants often lack specific clinical findings. Immaturity of humoral, cellular, and phagocytic immune function contributes to vulnerability, particularly among preterm infants. [15][22]

Meningitis and bacteremia are closely linked in neonates, but neither the presence nor absence of a sepsis syndrome reliably substitutes for CSF assessment when meningitis is clinically plausible. Diagnostic evaluation should therefore prioritize CSF testing when the infant’s cardiopulmonary status permits. [7][15]
- Treat suspected neonatal meningitis as a hospital-based emergency requiring diagnostic sampling and empiric IV antimicrobial therapy. [19][22]
- Consider health care-associated gram-negative pathogens in prolonged hospitalization or outbreak contexts; Citrobacter koseri has particular neonatal CNS tropism and may cause meningitis, encephalitis, and brain abscess. [23]

## Prioritize cerebrospinal fluid examination and culture

CSF testing establishes the diagnosis but must be balanced against physiologic stability.

The diagnosis of bacterial meningitis rests on CSF examination after lumbar puncture, and CSF culture is the reference standard for confirmation of neonatal bacterial meningitis. [4][7] Obtain CSF before antibiotics whenever this does not cause clinically important delay or compromise stabilization; antibiotic administration can reduce culture sensitivity. [11]

CSF cell count, protein, glucose, Gram stain, and culture should be interpreted together rather than as isolated exclusionary tests. In neonatal practice, CSF interpretation can be difficult, including after a traumatic lumbar puncture. A CSF white-cell count greater than 100/mm3 has been used as a threshold in studies addressing probable culture-negative meningitis, but no consensus definition of culture-negative neonatal meningitis exists. [3][5][10]

Molecular assays may identify pathogens missed by culture. In pediatric meningitis surveillance, PCR was positive in 9% of culture-negative specimens in one report; however, molecular testing should complement rather than replace conventional CSF examination and culture. [8]
- Do not defer empiric treatment solely to obtain an LP in an infant whose respiratory or hemodynamic condition makes the procedure unsafe. [3]
- Interpret a negative CSF culture cautiously after antimicrobial exposure. [11]
- Use CSF results with the infant’s clinical condition when determining whether culture-negative disease requires a meningitis treatment course; evidence for a single CSF threshold is limited. [4][5]

*Decision-focused interpretation of available neonatal meningitis diagnostic evidence*

| Finding or circumstance | Clinical implication |
| --- | --- |
| CSF culture positive | Confirms bacterial meningitis; culture is the diagnostic reference standard. [4][11] |
| Antibiotics administered before LP | Culture sensitivity may be reduced; integrate CSF indices, microbiology, and clinical course. [11] |
| CSF WCC >100/mm3 | Has been used in research definitions of probable culture-negative neonatal meningitis, but consensus is lacking. [5] |
| Unstable respiratory status | LP may compromise respiratory function; stabilize and begin treatment rather than forcing immediate LP. [3] |

## Start empiric intravenous therapy without avoidable delay

Regimen selection must cover expected neonatal pathogens while culture data are pending.

Early empiric antibiotic therapy is considered critical because delayed recognition of neonatal meningitis is common and the condition carries substantial mortality and morbidity. [22] Common pathogens in infants younger than 3 months in developed settings include group B Streptococcus, Escherichia coli, and Listeria monocytogenes. [15]

A recent systematic review of meningitis treatment in infants aged 0 to 59 days reports that IV aminopenicillins and third- and fourth-generation cephalosporins achieve high CSF-to-plasma concentration ratios, particularly with meningeal inflammation. [19] The supplied evidence supports ampicillin plus cefotaxime or ceftriaxone as an antimicrobial approach described for meningitis in immunocompetent infants younger than 3 months, while ampicillin plus gentamicin is described for neonatal sepsis rather than as the preferred meningitis-specific combination. [15]

The reviewed literature does not provide sufficiently supported U.S. neonatal dose, interval, renal-adjustment, or postmenstrual-age dosing details. Select dosing from current institutional neonatal formularies and infectious diseases or neonatal pharmacy guidance rather than extrapolating from this evidence set.
- Ampicillin provides coverage for pathogens including group B Streptococcus and Listeria in the epidemiologic framework described for young infants. [15]
- Use an extended-spectrum cephalosporin as the companion agent when treating suspected meningitis in the regimen described for young infants. [15][19]
- Cefotaxime has traditionally been preferred to ceftriaxone because of lower plasma-protein affinity and concern for bilirubin displacement; recent studies cited in the systematic review did not show increased hyperbilirubinemia among treated term infants. [19]
- Routine adjunctive corticosteroids are not supported for neonatal bacterial meningitis because evidence is insufficient. [14]

### When to broaden initial coverage

Hospital-acquired infection, prior antimicrobial exposure, local resistance patterns, and unusual organisms should prompt individualized empiric selection with neonatal infectious diseases input. Citrobacter species can be health care-associated, and C. koseri CNS infection is associated with severe neonatal complications including brain abscess. [23]
- Do not apply adult community-acquired meningitis empiric regimens, including routine vancomycin-based recommendations, directly to neonatal disease without pathogen, exposure, and local susceptibility assessment. [1][15]

*Antimicrobial selection considerations supported by the available evidence*

| Decision | Evidence-supported consideration |
| --- | --- |
| Initial regimen for suspected meningitis in infants <3 months | Ampicillin plus cefotaxime or ceftriaxone is described for immunocompetent infants in developed settings. [15] |
| Why include an aminopenicillin | Young-infant epidemiology includes group B Streptococcus and Listeria monocytogenes. [15] |
| Cefotaxime versus ceftriaxone | Cefotaxime has traditionally been preferred because of lower protein binding and theoretical lower bilirubin-displacement risk. [19] |
| Adjunctive corticosteroids | Insufficient evidence supports routine use in neonatal bacterial meningitis. [14] |

## Individualize duration and monitor for CNS complications

Culture results and clinical evolution should guide definitive management.

Treatment duration should be pathogen-directed when microbiology is available. For an unknown pathogen, guidance summarized in a 2024 systematic review recommends hospital treatment for up to 3 weeks. The review notes that these recommendations were developed from early trials and expert opinion, underscoring a need to individualize care rather than treat this duration as high-certainty evidence. [19]

Documented CSF pathogen clearance correlates with clinical improvement in the evidence reviewed for young infants. [19] If the clinical course is not improving, if CSF remains concerning, or if an organism associated with destructive CNS disease is identified, reassess microbiology, antimicrobial susceptibility, source control needs, and neuroimaging strategy with subspecialty input.

C. koseri warrants particular attention because neonatal CNS infection may manifest as meningitis, encephalitis, or brain abscess. [23] Survivors require longitudinal developmental surveillance because neonatal meningitis continues to cause substantial neurologic disability. [15][22]
- Narrow or modify therapy when CSF culture and susceptibility results identify a pathogen; the supplied sources do not support organism-specific durations or neonatal doses. [19]
- Escalate evaluation for focal CNS complications when the clinical course is atypical or when organisms associated with abscess are recovered. [23]
- Arrange neurodevelopmental follow-up after confirmed neonatal bacterial meningitis. [15][22]

## Maternal GBS prophylaxis reduces early neonatal infectious risk

Intrapartum prevention affects early-onset GBS disease risk, not all neonatal meningitis.

Maternal intrapartum beta-lactam prophylaxis for GBS is most effective when initiated at least 4 hours before birth. In a cohort of 7,691 births, neonatal diagnostic evaluations for sepsis and empiric antibiotic use occurred in 1.6% after less than 2 hours of prophylaxis, 0.9% after 2 to less than 4 hours, and 0.4% after at least 4 hours. [13]

Shorter exposure is less effective, although 2 hours of recommended intrapartum antibiotics reduces vaginal GBS colony counts. Obstetric interventions should not be delayed solely to complete 4 hours of prophylaxis. [13]

## Common questions

### Should antibiotics wait until after lumbar puncture in suspected neonatal meningitis?

Obtain CSF before antibiotics when clinically feasible, but do not delay treatment when stabilization is required or LP may compromise respiratory function. Antibiotic exposure can reduce CSF culture sensitivity. [3][11]

### Can a negative CSF culture exclude neonatal meningitis?

No. CSF culture is the reference standard, but sensitivity is affected by prior antibiotics. Interpret culture-negative results with CSF indices, microbiologic testing, and the clinical course. [4][11]

### Is dexamethasone routinely indicated in neonatal bacterial meningitis?

No. Available evidence is insufficient to support routine corticosteroid use in neonatal bacterial meningitis, unlike evidence summarized for some nonneonatal bacterial meningitis populations. [14]

### How long should culture-negative neonatal meningitis be treated?

A recent systematic review reports guidance supporting hospital therapy for up to 3 weeks when the pathogen is unknown, but emphasizes that this recommendation derives largely from early trials and expert opinion. [19]

## References
1. Community-Acquired Bacterial Meningitis — www.nejm.org — https://www.nejm.org/doi/pdf/10.1056/NEJMc060228
2. Incidence of and Outcomes After Late-Onset Meningitis ... — jamanetwork.com — https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2799308
3. Lumbar puncture in suspected neonatal sepsis - McINTYRE — onlinelibrary.wiley.com — https://onlinelibrary.wiley.com/doi/abs/10.1111/j.1440-1754.1995.tb02899.x
4. The clinical condition rather than cerebrospinal fluid levels ... — onlinelibrary.wiley.com — https://onlinelibrary.wiley.com/doi/full/10.1002/pdi3.43
5. C‐reactive protein and immature‐to‐total neutrophil ratio ... — onlinelibrary.wiley.com — https://onlinelibrary.wiley.com/doi/10.1111/jpc.13890
6. Cerebrospinal fluid and plasma procalcitonin for the ... — onlinelibrary.wiley.com — https://onlinelibrary.wiley.com/doi/10.1111/jpc.16023
7. Practice Guidelines for the Management of Bacterial Meningitis — academic.oup.com — https://academic.oup.com/cid/article/39/9/1267/402080
8. Role of Molecular Testing in Pediatric Meningitis Surveillance ... — academic.oup.com — https://academic.oup.com/jid/article/224/Supplement_3/S194/6361067
9. Metagenomic Next-Generation Sequencing for Pathogen ... — academic.oup.com — https://academic.oup.com/ofid/advance-article-pdf/doi/10.1093/ofid/ofab104/36497116/ofab104.pdf
10. Adjustment of cerebrospinal fluid protein for red blood cells in ... — shmpublications.onlinelibrary.wiley.com — https://shmpublications.onlinelibrary.wiley.com/doi/10.1002/jhm.1920
11. Cerebrospinal Fluid Metagenomic Next-Generation ... — academic.oup.com — https://academic.oup.com/ofid/article-pdf/13/2/ofag054/66770841/ofag054.pdf
12. Neuroinfectious Emergencies - Continuum — journals.lww.com — https://journals.lww.com/continuum/fulltext/2024/06000/neuroinfectious_emergencies.11.aspx
13. Prevention of Group B Streptococcal Early-Onset... : Obstetrics & Gynecology — journals.lww.com — https://journals.lww.com/greenjournal/fulltext/10.1097/aog.0000000000003668~prevention-of-group-b-streptococcal-early-onset-disease-in
14. Corticosteroids as adjunctive therapy in acute... : Annals of Medicine & Surgery — journals.lww.com — https://journals.lww.com/annals-of-medicine-and-surgery/_layouts/15/oaks.journals/downloadpdf.aspx?an=01845215-202602000-00055
15. Neonatal Meningitis - an overview — www.sciencedirect.com — https://www.sciencedirect.com/topics/immunology-and-microbiology/neonatal-meningitis
16. Long-term impact of serious neonatal bacterial infections ... — www.sciencedirect.com — https://www.sciencedirect.com/science/article/pii/S1198743X23001908
17. Epidemiology and Trends of Infective Meningitis in ... — www.sciencedirect.com — https://www.sciencedirect.com/science/article/pii/S1201971221005142
18. Neonatal bacterial meningitis: an update — www.sciencedirect.com — https://www.sciencedirect.com/science/article/abs/pii/S1751722210000922
19. Efficacy of Antibiotic Regimens for Meningitis in Young Infants Aged 0–59 Days: A Systematic Review | Pediatrics | American Academy of Pediatrics — publications.aap.org — https://publications.aap.org/pediatrics/article/154/Supplement%201/e2024066588H/198468/Efficacy-of-Antibiotic-Regimens-for-Meningitis-in
20. 2016 Update by the Infectious Diseases Society of America — www.ccjm.org — https://www.ccjm.org/lookup/external-ref?access_num=10.1093%2Fcid%2Fciv933&link_type=DOI
21. Neonatal Meningitis in the New Millennium | NeoReviews | American Academy of Pediatrics — publications.aap.org — https://publications.aap.org/neoreviews/article/4/3/e73/88514/Neonatal-Meningitis-in-the-New-Millennium
22. Neonatal Bacterial Meningitis | NeoReviews | American Academy of Pediatrics — publications.aap.org — https://publications.aap.org/neoreviews/article/16/9/e535/88433/Neonatal-Bacterial-Meningitis
23. Hospital-Acquired Citrobacter Meningitis Complicated by Pneumocephalus in a Neonate | Pediatrics | American Academy of Pediatrics — publications.aap.org — https://publications.aap.org/pediatrics/article/doi/10.1542/peds.2025-072882/206459/Hospital-Acquired-Citrobacter-Meningitis?searchresult=1
24. Bacterial Infections: Pediatric OIs | NIH — clinicalinfo.hiv.gov — https://clinicalinfo.hiv.gov/en/guidelines/hiv-clinical-guidelines-pediatric-opportunistic-infections/bacterial-infections

## Editorial note

Prepared from cited clinical literature using Astra's research workflow. Verify recommendations against current guidance and patient-specific factors.